Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem announces award of its US patent for creation of Retinal Pigment Epithelium, Photoreceptors and Retinal Organoids
Home
update
Eyestem announces award of its US patent for creation of Retinal Pigment Epithelium, Photoreceptors and Retinal Organoids
Post Author:
eyetem@admin
Post navigation
Previous Post
Endiya Partners invest in Cell Therapy Company Eyestem
Next Post
Eyestem Research moves one step closer in finding a treatment for Dry AMD and announces successful animal experiments for its flagship product.
